What To Expect From PFE Stock In 2025?
In this note, while we briefly touch upon Pfizer’s performance in 2024, we focus on the impact on PFE stock and how 2025 ...
The past three years for Pfizer (NYSE:PFE) investors has not been profitable
For many investors, the main point of stock picking is to generate higher returns than the overall market. But if ...
Hosted on MSN10mon
What's Going On With Pfizer Stock Wednesday?
Pfizer Inc (NYSE:PFE ... Like A Toilet' While On His Death Bed — But She Clar Must Read: New York Community Bancorp Stock Halted After News Of Bank Seeking Capital Infusion, Shares Down 40% ...
Pfizer to pay $59.7 million over kickbacks for migraine drug
Pfizer will pay $59.7 million to resolve charges that a company it acquired defrauded Medicare and other healthcare programs ...
Pfizer Target of Unusually Large Options Trading (NYSE:PFE)
Pfizer Inc. (NYSE:PFE – Get Free Report) saw unusually large options trading activity on Thursday. Traders acquired 251,131 ...
Pfizer (PFE) Receives a Hold from Citi
Citi analyst Geoff Meacham maintained a Hold rating on Pfizer (PFE – Research Report) today. The company’s shares closed yesterday at ...
MarketWatch1mon
Pfizer Boost Quarterly Dividend by 2.4% to 43c
Pfizer on Thursday said it will raise its quarterly dividend by 2.4%. The New York-based drug company on Thursday said its board increased its cash dividend to 43 cents a share from 42 cents.
Pfizer Stock: Settlement Cost Triggers Share Price Drop
Pfizer's stock experienced a notable decline on Friday at the New York Stock Exchange, falling 1.6% to $26.03 per share following news of a $59.7 million settlement payment. The settlement stems from ...
Bernstein Reaffirms Their Hold Rating on Pfizer (PFE)
Bernstein analyst Courtney Breen maintained a Hold rating on Pfizer (PFE – Research Report) today and set a price target of $32.00. The ...
Pfizer appeals denial of $75 million claim in SEC case against Cohen hedge fund
Pfizer on Tuesday appealed a federal judge's refusal to award the drugmaker $75.2 million from a more than decade-old insider ...